Roflumilast is used for treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD) exacerbations in ...

Senores Pharmaceutical added 2.18% to Rs 546.15 after the company's wholly owned subsidiary, Senores Pharmaceuticals, Inc., USA has signed an agreement to acquire Roflumilast 250 mcg and 500 mcg ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

By analyzing multiple emphysema and COPD patient datasets, SPP1 is significantly upregulated in the lungs of patients, ...

The partnership will enhance the clinic’s ability to provide specialized respiratory care and reinforce its commitment to ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...

As Pope Francis battles dangerous lung infection, here’s what you need to know about the causes, symptoms, prevention tips ...